Sharps Technology

Pending $400 Million Purchase Agreement To Advance Sharps Into Large Prefillable Syringe Market With Differentiated Copolymer Syringe Systems

Sponsored

Sharps Technology (STSS) To Enter The Copolymer Prefillable Syringe Market With Strength And Ahead of Plan Through Pending Manufacturing Facility Acquisition and $400M Nephron Deal

Sponsored

Sharps Technology CEO Robert Hayes Issues Update Letter To Shareholders

Sponsored

Sharps Technology (STSS) To Enter The Copolymer Prefillable Syringe Market With Strength And Ahead of Plan Through Pending Manufacturing Facility Acquisition and $400M Nephron Deal

Sponsored

Sharps Technology CEO Robert Hayes Issues Update Letter To Shareholders

Sponsored

Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?

Sponsored

With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO

Sponsored

Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?

Sponsored

With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO

Sponsored

Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products

Sponsored

Sharps Technology To Launch Next-Gen Prefillable Syringe Systems In Collaboration With Nephron Pharmaceuticals In 2023

Sponsored

Sharps Technology Recent News

Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry

Medical device company Sharps Technology, Inc. (NASDAQ: STSS) is closing out a successful year after its April initial public offering (IPO) on the NASDAQ market. The company focuses on the development of innovative drug delivery technology in the market.

Sponsored